The Worldwide Anesthetic Drugs is Expected to Reach $6.4 Billion by 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Anesthetic Drugs Market (2021-2026) by Drug Type, Route of Administration, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Anesthetic Drugs Market is estimated to be USD 4.68 Bn in 2021 and is expected to reach USD 6.42 Bn by 2026, growing at a CAGR of 6.52%.

The major factors driving the growth of the global anesthetic drugs market are the growing number of operations such as cardiac, orthopedic, general surgeries, and pain management.

Furthermore, technological advancements in drug delivery devices, the development of specific targeted drugs, and patient monitoring devices for monitoring physiological parameters of patients during and after anesthesia and reduced anesthetic drug side effects are all expected to drive market growth over the forecast period. In addition, the decreasing cost of newly created medications and the decrease in the recovery period after surgery is creating more opportunities for the market.

However, some side-effects caused by anesthetic drugs, including nausea, vomiting, disorientation, sore throat, muscle aches, etc., and stringent policy and regulations imposed by the government are restraining and creating challenges for the market growth.

The Global Anesthetic Drugs Market is segmented based on Drug Type, Route of Administration, Application, and Geography.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Anesthetic Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Market Dynamics

Drivers

• Increase in Surgical Procedures
• Substantial Demand for Post-Operative Pain Relief Options
• The Rise in Pain Management

Restraints

• Side Effects of Some Anesthetic Drugs

Opportunities

• Innovations in Drug Delivery Technologies
• Growing Healthcare Sectors in Developing Countries

Challenges

• Lack of Skilled-Anesthetics

Companies Mentioned

• Abbott Laboratories
• AbbVie Inc
• Aspen Pharmacare Holdings Limited
• AstraZeneca plc
• B. Braun Melsungen AG
• Baxter International Inc
• Claris Lifesciences Limited
• Dr. Reddy’s Laboratories
• Eisai Co. Ltd
• F. Hoffmann-La Roche Ltd
• Fresenius SE & Co. KGaA
• Glenmark Pharmaceuticals Limited
• Hikma Pharmaceuticals PLC
• Hospira, Inc
• Maruishi Pharmaceutical Co., Ltd
• Nuventra Pharma Sciences
• Pacira Pharmaceuticals, Inc
• Paion UK Ltd
• Pfizer Inc
• Piramal Enterprises LTD
• Septodont Healthcare India Pvt. Ltd
• Slayback Pharma LLC
• Teva Pharmaceutical Industries Limited
• Troikaa Pharmaceuticals Ltd.
• Viatris Inc

For more information about this report visit https://www.researchandmarkets.com/r/ur0z0v

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900